top of page

Teléfono: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

​Inicio >

Afrezza Inhaler Device

Afrezza Inhaler Device

Manufacturer/Marketed By : CIPLA LTD

$1.05 $0.94

The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Active Pharmaceutical Ingredient

Afrezza Inhaler Device

SKU AFREZZA-INHALER-DEVICE
Precio original

1,05 US$

Precio de oferta

0,94 US$

The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type 2 diabetes who need rapid-acting insulin to control blood sugar levels after meals. The Afrezza Inhaler effectiveness lies in its fast absorption through the lungs, which helps reduce post-meal glucose spikes. Unlike injections, this device offers a needle-free option for insulin delivery. The Afrezza Inhaler Device does not contain insulin on its own. It works only with Afrezza insulin cartridges that contain dry powder human insulin. The inhaler itself is reusable, while the cartridges are single-use and available in different strengths. Afrezza Inhaler dosage is decided by the doctor based on meal size, blood sugar readings, and individual insulin needs. Many patients ask, Is Afrezza safe for teenagers, and its use in younger individuals should be determined strictly by a healthcare professional. As with any insulin therapy, users should be aware of possible Afrezza Inhaler side effects, such as cough, throat irritation, or low blood sugar. Before starting therapy, patients should receive proper training to ensure correct inhalation technique and safe use. Those considering treatment often enquire about the Afrezza Inhaler price, which may vary depending on availability and pharmacy. Always consult a healthcare provider to confirm suitability and correct usage before starting Afrezza therapy.

Active Pharmaceutical Ingredient

​Usos

• Mealtime blood glucose control in adults with type 1 diabetes (used in combination with long-acting basal insulin).
• Mealtime blood glucose control in adults with type 2 diabetes who require insulin therapy.
• Reduction of postprandial (after-meal) blood sugar spikes.

Beneficios

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Efectos secundarios

Common Side Effects:

Efectos secundarios más comunes

• Bronchospasm
• Decline in lung function
• Severe hypoglycemia
• Allergic reactions

Efectos secundarios comunes

• Cough
• Throat irritation
• Hypoglycemia
• Headache

​Cómo utilizar

To use the Afrezza Inhaler Device:

Consejos de seguridad

• Pregnancy: Insulin therapy may be required during pregnancy, but the suitability of inhaled insulin should be assessed by a doctor.
• Breast Feeding: Limited data is available on the use of inhaled insulin during breastfeeding. Medical advice is recommended before use.
• Lungs: Afrezza is contraindicated in patients with chronic lung diseases such as asthma or COPD. Baseline and periodic lung function tests are required.
• Liver: Insulin requirements may vary in patients with liver impairment. Regular monitoring is advised.
• Alcohol: Alcohol can affect blood sugar control and increase the risk of hypoglycemia. Use with caution.
• Driving: Hypoglycemia can impair concentration and reaction time. Avoid driving if symptoms occur.

​Descargo de responsabilidad

Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.

Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.

Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.

Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.

bottom of page